Kenneth Hallock's most recent trade in Greenwich LifeSciences Inc was a trade of 41,349 Stock Options done . Disclosure was reported to the exchange on Dec. 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 41,349 | 82,698 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 41,349 | 41,349 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 16.32 per share. | 21 Jan 2022 | 300 | 397,304 | - | 16.3 | 4,896 | Common Stock |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 5.39 per share. | 24 Nov 2020 | 1,000 | 397,004 | - | 5.4 | 5,386 | Common Stock |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 5.37 per share. | 20 Nov 2020 | 1,000 | 396,004 | - | 5.4 | 5,370 | Common Stock |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 79,121 | 386,671 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 79,121 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 5.75 per share. | 29 Sep 2020 | 74,782 | 257,368 | - | 5.8 | 429,997 | Common Stock |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 18,727 | 276,095 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 18,727 | 0 | - | - | Series B Preferred Stock | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 18,727 | 0 | - | - | Series C Preferred Stock | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 18,727 | 294,822 | - | - | Common Stock | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2020 | 12,728 | 0 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Other type of transaction at price $ 0.00 per share. | 29 Sep 2020 | 12,728 | 12,728 | - | - | Series D Preferred Stock | |
| Greenwich LifeSciences Inc | Kenneth Hallock | Director | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 29 Sep 2020 | 8,333 | 395,004 | - | 4.6 | 38,353 | Common Stock |